Assessment of serum L-fucose in brain tumor cases.
Ann Indian Acad Neurol
; 13(1): 33-6, 2010 Jan.
Article
em En
| MEDLINE
| ID: mdl-20436744
ABSTRACT
BACKGROUND:
Glycosylation of altered tumor cell in relation to cellular heterogeneity in human intracranial tumors remains relatively unexposed. Serum protein-bound carbohydrate, L-Fucose is reported to be overexpressed during tumor progression by many investigators. Therefore, there is a need to determine the diagnostic, prognostic, functional significance of glycoprotein elevations in various cases of tumors.OBJECTIVE:
The objective of the present study was to evaluate the clinical utility of serum L-fucose in patients with brain tumor. MATERIALS ANDMETHODS:
Serum glyco-conjugate levels were estimated in 99 patients with brain tumors. Estimation of L-fucose was carried out colorimetrically by the method of Winzler using cysteine hydrochloride.RESULTS:
There was a significant increase in L-fucose level in most of the patients. In the posttreatment cases, the L-fucose levels were apparently low compared to preoperative values.CONCLUSION:
Our results showed that the rise in serum L-fucose may be used as a general marker for brain tumors in addition to other markers.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article